OX40L–OX40 Signaling in Atopic Dermatitis

OX40 is one of the co-stimulatory molecules expressed on T cells, and it is engaged by OX40L, primarily expressed on professional antigen-presenting cells such as dendritic cells. The OX40L–OX40 axis is involved in the sustained activation and expansion of effector T and effector memory T cells, but it is not active in naïve and resting memory T cells. Ligation of OX40 by OX40L accelerates both T helper 1 (Th1) and T helper 2 (Th2) effector cell differentiation. Recent therapeutic success in clinical trials highlights the importance of the OX40L–OX40 axis as a promising target for the treatment of atopic dermatitis.

[1]  S. Tsoka,et al.  Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action , 2021, European journal of immunology.

[2]  M. Worm,et al.  Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis. , 2021, The journal of allergy and clinical immunology. In practice.

[3]  S. Shin,et al.  Fms-Like Tyrosine Kinase 3-Independent Dendritic Cells Are Major Mediators of Th2 Immune Responses in Allergen-Induced Asthmatic Mice , 2020, International journal of molecular sciences.

[4]  Suzie Chen,et al.  Overcoming Immune Evasion in Melanoma , 2020, International journal of molecular sciences.

[5]  M. Croft,et al.  Combination Blockade of OX40L and CD30L Inhibits Allergen-driven Memory Th2 Reactivity and Lung Inflammation. , 2020, The Journal of allergy and clinical immunology.

[6]  M. Furue.  Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis , 2020, Journal of clinical medicine.

[7]  M. Furue,et al.  Basics and recent advances in the pathophysiology of atopic dermatitis , 2020, The Journal of dermatology.

[8]  S. Raghavan,et al.  Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer , 2020, Scandinavian journal of immunology.

[9]  G. Ciliberto,et al.  T-cell agonists in cancer immunotherapy , 2020, Journal for ImmunoTherapy of Cancer.

[10]  T. Vyse,et al.  Th1 responses in vivo require cell-specific provision of OX40L dictated by environmental cues , 2020, Nature Communications.

[11]  H. Nakagawa,et al.  Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis. , 2020, Journal of dermatological science.

[12]  C. Phoenix,et al.  A Highly Polarized Th2 Bladder Response to Infection Promotes Epithelial Repair at the Expense of Preventing New Infections , 2020, Nature Immunology.

[13]  C. Vestergaard,et al.  The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis , 2020, Acta dermato-venereologica.

[14]  D. Nandi,et al.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy , 2020, Journal of Biosciences.

[15]  B. Routy,et al.  New pathways in immune stimulation: targeting OX40 , 2020, ESMO Open.

[16]  Feipeng Zhao,et al.  Effect of Blocking the OX40/OX40L Signaling Pathway by siRNA Interference on Animal Experimental Study of Allergic Rhinitis. , 2019, Archives of medical research.

[17]  Zhen Bian,et al.  Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases. , 2019, Journal of autoimmunity.

[18]  Beixing Liu,et al.  Critical role of OX40/OX40L in ILC2-mediated activation of CD4+T cells during respiratory syncytial virus infection in mice. , 2019, International immunopharmacology.

[19]  G. Gudi,et al.  GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. , 2019, The Journal of allergy and clinical immunology.

[20]  M. Furue,et al.  Pathogenesis of Atopic Dermatitis: Current Paradigm. , 2019, Iranian journal of immunology : IJI.

[21]  V. Pascual,et al.  OX40L/OX40 axis impairs follicular and natural Treg function in human SLE. , 2018, JCI insight.

[22]  Kaifu Chen,et al.  OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms. , 2018, Cell reports.

[23]  S. Teichmann,et al.  Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells , 2018, Immunity.

[24]  E. Israel,et al.  The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation , 2018, Nature Communications.

[25]  O. Burlet-Schiltz,et al.  Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33 , 2018, Nature Immunology.

[26]  R. Zheng,et al.  The TH2-polarizing function of atopic interleukin 17 receptor B-positive dendritic cells up-regulated by lipopolysaccharide. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[27]  A. Paller,et al.  Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. , 2016, The Journal of allergy and clinical immunology.

[28]  Xiaoming Shi,et al.  The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways. , 2016, Immunity.

[29]  G. Hirschfield,et al.  OX40, OX40L and Autoimmunity: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.

[30]  T. Honda,et al.  The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. , 2015, The Journal of allergy and clinical immunology.

[31]  H. Hammad,et al.  Barrier Epithelial Cells and the Control of Type 2 Immunity. , 2015, Immunity.

[32]  M. Furue,et al.  Mutual upregulation of endothelin‐1 and IL‐25 in atopic dermatitis , 2015, Allergy.

[33]  Tony T. Jiang,et al.  Commensal microbes drive intestinal inflammation by IL-17–producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2 , 2014, Proceedings of the National Academy of Sciences.

[34]  A. Iwasaki,et al.  CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity. , 2013, Immunity.

[35]  M. Suárez-Fariñas,et al.  Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.

[36]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[37]  I. Harvima,et al.  OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[38]  J. Carucci,et al.  Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. , 2011, The Journal of allergy and clinical immunology.

[39]  G. Anderson,et al.  Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice , 2011, The Journal of experimental medicine.

[40]  D. Spencer,et al.  Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. , 2010, The American journal of pathology.

[41]  S. Ziegler,et al.  Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. , 2010, The Journal of allergy and clinical immunology.

[42]  H. Dickel,et al.  Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL‐33, TNF‐α and IL‐8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’ , 2010, Contact dermatitis.

[43]  M. Croft.  Control of immunity by the TNFR-related molecule OX40 (CD134). , 2010, Annual review of immunology.

[44]  T. So,et al.  The significance of OX40 and OX40L to T‐cell biology and immune disease , 2009, Immunological reviews.

[45]  A. Cunningham,et al.  Critical Synergy of CD30 and OX40 Signals in CD4 T Cell Homeostasis and Th1 Immunity to Salmonella1 , 2008, The Journal of Immunology.

[46]  D. Seshasayee,et al.  In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. , 2007, The Journal of clinical investigation.

[47]  Wenda Gao,et al.  OX40 costimulation turns off Foxp3+ Tregs. , 2007, Blood.

[48]  Tomoki Ito,et al.  TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.

[49]  Yu Wang,et al.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.

[50]  M. Croft,et al.  Costimulation of CD8 T Cell Responses by OX401 , 2004, The Journal of Immunology.

[51]  S. Antonenko,et al.  Human Dendritic Cells Activated by TSLP and CD40L Induce Proallergic Cytotoxic T Cells , 2003, The Journal of experimental medicine.

[52]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[53]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[54]  A. Gurney,et al.  Forced Expression of Murine IL-17E Induces Growth Retardation, Jaundice, a Th2-Biased Response, and Multiorgan Inflammation in Mice , 2001, The Journal of Immunology.

[55]  M. Croft,et al.  Development of Allergic Inflammation in a Murine Model of Asthma Is Dependent on the Costimulatory Receptor Ox40 , 2001, The Journal of experimental medicine.

[56]  M. Croft,et al.  The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion1 , 2000, The Journal of Immunology.

[57]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[58]  K. Takase,et al.  [T cell activation]. , 1995, Ryumachi. [Rheumatism].

[59]  Li Li,et al.  Negative regulation of IL-17 production by OX40/OX40L interaction. , 2008, Cellular immunology.

[60]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.